These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 20150524

  • 1. Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma.
    Xu J, Nave R, Lahu G, Derom E, Derendorf H.
    J Clin Pharmacol; 2010 Oct; 50(10):1118-27. PubMed ID: 20150524
    [Abstract] [Full Text] [Related]

  • 2. Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma.
    Derom E, Louis R, Tiesler C, Engelstätter R, Kaufman JM, Joos GF.
    Eur Respir J; 2009 Jun; 33(6):1277-86. PubMed ID: 19164356
    [Abstract] [Full Text] [Related]

  • 3. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK, Fardon TC, Bates CE, Haggart K, McFarlane LC, Lipworth BJ.
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [Abstract] [Full Text] [Related]

  • 5. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
    Derom E, Van De Velde V, Marissens S, Engelstätter R, Vincken W, Pauwels R.
    Pulm Pharmacol Ther; 2005 Jan; 18(5):328-36. PubMed ID: 15939311
    [Abstract] [Full Text] [Related]

  • 6. Effects of hydrofluoroalkane formulations of ciclesonide 400 microg once daily vs fluticasone 250 microg twice daily on methacholine hyper-responsiveness in mild-to-moderate persistent asthma.
    Lee DK, Haggart K, Currie GP, Bates CE, Lipworth BJ.
    Br J Clin Pharmacol; 2004 Jul; 58(1):26-33. PubMed ID: 15206989
    [Abstract] [Full Text] [Related]

  • 7. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma.
    Szefler S, Rohatagi S, Williams J, Lloyd M, Kundu S, Banerji D.
    Chest; 2005 Sep; 128(3):1104-14. PubMed ID: 16162694
    [Abstract] [Full Text] [Related]

  • 8. Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.
    Chuchalin A, Jacques L, Frith L.
    Clin Drug Investig; 2008 Sep; 28(3):169-81. PubMed ID: 18266402
    [Abstract] [Full Text] [Related]

  • 9. Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients.
    Kim K, Quesada J, Szmaydy-Rikken N, Darken P, Shah T.
    J Asthma; 2007 Sep; 44(7):515-20. PubMed ID: 17885853
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma.
    Richter K, Kanniess F, Biberger C, Nave R, Magnussen H.
    J Clin Pharmacol; 2005 Feb; 45(2):146-52. PubMed ID: 15647406
    [Abstract] [Full Text] [Related]

  • 11. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
    Bateman ED, Linnhof AE, Homik L, Freudensprung U, Smau L, Engelstätter R.
    Pulm Pharmacol Ther; 2008 Feb; 21(2):264-75. PubMed ID: 17604664
    [Abstract] [Full Text] [Related]

  • 12. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    FitzGerald JM, Boulet LP, Follows RM.
    Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
    [Abstract] [Full Text] [Related]

  • 13. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
    Baraniuk J, Murray JJ, Nathan RA, Berger WE, Johnson M, Edwards LD, Srebro S, Rickard KA.
    Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263
    [Abstract] [Full Text] [Related]

  • 14. A comparative study of inhaled ciclesonide 160 microg/day and fluticasone propionate 176 microg/day in children with asthma.
    Pedersen S, Garcia Garcia ML, Manjra A, Theron I, Engelstätter R.
    Pediatr Pulmonol; 2006 Oct; 41(10):954-61. PubMed ID: 16868976
    [Abstract] [Full Text] [Related]

  • 15. Model-based covariate pharmacokinetic analysis and lack of cortisol suppression by the new inhaled corticosteroid ciclesonide using a novel cortisol release model.
    Rohatagi S, Krishnaswami S, Pfister M, Sahasranaman S.
    Am J Ther; 2005 Oct; 12(5):385-97. PubMed ID: 16148423
    [Abstract] [Full Text] [Related]

  • 16. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
    Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T.
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143
    [Abstract] [Full Text] [Related]

  • 17. Salmeterol and fluticasone propionate given as a combination. Lack of systemic pharmacodynamic and pharmacokinetic interactions.
    Kirby S, Falcoz C, Daniel MJ, Milleri S, Squassante L, Ziviani L, Ventresca GP.
    Eur J Clin Pharmacol; 2001 Jun; 56(11):781-91. PubMed ID: 11294367
    [Abstract] [Full Text] [Related]

  • 18. Equivalent pharmacokinetics of the active metabolite of ciclesonide with and without use of the AeroChamber Plus spacer for inhalation.
    Drollmann A, Nave R, Steinijans VW, Baumgärtner E, Bethke TD.
    Clin Pharmacokinet; 2006 Jun; 45(7):729-36. PubMed ID: 16802853
    [Abstract] [Full Text] [Related]

  • 19. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A, Jarvis B.
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effect of low-dose ciclesonide and fixed-dose fluticasone propionate and salmeterol combination on long-term asthma control.
    Postma DS, O'Byrne PM, Pedersen S.
    Chest; 2011 Feb; 139(2):311-318. PubMed ID: 21088114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.